|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▼
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
TRABECTEDIN |
L01CX01 |
DE
|
POM
|
19-07-2023 |
|
|
VALID
|
|
VARIOUS COMBINATIONS |
B03AE10 |
DE
|
Not authorised
|
19-07-2023 |
|
|
VALID
|
|
VORICONAZOLE |
J02AC03 |
DE
|
POM
|
19-07-2023 |
|
|
VALID
|
|
ZINC SULFATE |
A12CB01 |
DE
|
POM
|
19-07-2023 |
|
|
VALID
|
|
DABRAFENIB |
L01EC02 |
DE
|
Not authorised
|
18-07-2023 |
|
|
VALID
|
|
FERRIC MALTOL |
B03AB10 |
DE
|
POM
|
18-07-2023 |
|
|
VALID
|
|
OSIMERTINIB |
L01EB04 |
DE
|
Not authorised
|
18-07-2023 |
|
|
VALID
|
|
PEGASPARGASE |
L01XX24 |
DE
|
POM
|
18-07-2023 |
|
|
VALID
|
|
TEMSIROLIMUS |
L01EG01 |
DE
|
Not authorised
|
18-07-2023 |
|
|
VALID
|
|
TRAMETINIB |
L01EE01 |
DE
|
Not authorised
|
18-07-2023 |
|
|
VALID
|
|
BOSUTINIB |
L01EA04 |
DE
|
POM
|
13-07-2023 |
|
|
VALID
|
|
EPINASTINE |
S01GX10 |
DE
|
POM
|
13-07-2023 |
|
|
VALID
|
|
NILOTINIB |
L01EA03 |
DE
|
Not authorised
|
13-07-2023 |
|
|
VALID
|
|
RAMIPRIL AND AMLODIPINE |
C09BB07 |
DE
|
POM
|
13-07-2023 |
DE/H/5074/004/ |
14-10-2015 |
VALID
|
|
BOSENTAN |
C02KX01 |
DE
|
POM
|
12-07-2023 |
DE/H/5017/002/ |
03-06-2015 |
VALID
|
|
ICATIBANT |
B06AC02 |
DE
|
POM
|
12-07-2023 |
|
01-08-2009 |
VALID
|
|
APALUTAMIDE |
L02BB05 |
DE
|
POM
|
31-05-2023 |
|
|
VALID
|
|
CEFUROXIME |
J01DC02 |
DE
|
POM
|
30-05-2023 |
DE/H/0912/002/ |
02-06-2014 |
VALID
|
|
ASCIMINIB |
L01EA06 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
ATIDARSAGENE AUTOTEMCEL |
A16AB21 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
AVALGLUCOSIDASE ALFA |
A16AB22 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005501 |
24-06-2022 |
VALID
|
|
CAPMATINIB |
L01EX17 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004845 |
20-06-2022 |
VALID
|
|
CILTACABTAGENE AUTOLEUCEL |
L01XL05 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
DIFELIKEFALIN |
V03AX04 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005612 |
25-04-2022 |
VALID
|
|
EFGARTIGIMOD ALFA |
L04AA58 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005849 |
10-08-2022 |
VALID
|
|
ENFORTUMAB VEDOTIN |
L01FX13 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005392 |
13-04-2022 |
VALID
|
|
FARICIMAB |
S01LA09 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
FOSDENOPTERIN |
A16AX19 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
INEBILIZUMAB |
L04AG10 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005818 |
25-04-2022 |
VALID
|
|
LASMIDITAN |
N02CC08 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
LENACAPAVIR |
J05AX31 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
LINZAGOLIX |
H01CC04 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005442 |
14-06-2022 |
VALID
|
|
LONAFARNIB |
A16AX20 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
MELPHALAN FLUFENAMIDE |
L01AA10 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005681 |
17-08-2022 |
VALID
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005481 |
15-09-2022 |
VALID
|
|
OLIPUDASE ALFA |
A16AB25 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004850 |
24-06-2022 |
VALID
|
|
RELUGOLIX |
L02BX04 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005353 |
29-04-2022 |
VALID
|
|
RIMEGEPANT |
N02CD06 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005725 |
25-04-2022 |
VALID
|
|
TEBENTAFUSP |
L01XX75 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004929 |
01-04-2022 |
VALID
|
|
TEZEPELUMAB |
R03DX11 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
TIXAGEVIMAB AND CILGAVIMAB |
J06BD03 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005788 |
25-03-2022 |
VALID
|
|
VOCLOSPORIN |
L04AD03 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
VUTRISIRAN |
N07XX18 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
AZELASTINE |
S01GX07 |
DE
|
Not subject to prescription
|
23-02-2023 |
DE/H/3852/001/ |
17-11-2014 |
VALID
|
|
EMEDASTINE |
S01GX06 |
DE
|
POM
|
23-02-2023 |
|
|
VALID
|
|
DARUNAVIR |
J05AE10 |
DE
|
POM
|
21-11-2022 |
|
|
VALID
|
|
LITHIUM |
N05AN01 |
DE
|
POM
|
12-07-2022 |
DE/H/4351/001/ |
16-03-2016 |
VALID
|
|
MOXIFLOXACIN |
J01MA14 |
DE
|
POM
|
12-07-2022 |
DE/H/3966/001/ |
02-03-2015 |
VALID
|
|
NORFLOXACIN |
J01MA06 |
DE
|
POM
|
12-07-2022 |
DE/H/2420/001/II/001 |
07-05-2009 |
VALID
|
|
OFLOXACIN |
J01MA01 |
DE
|
POM
|
12-07-2022 |
DE/H/0317/001/II/013 |
16-11-2009 |
VALID
|
